Editorial: Psychoactive natural products: Potential in the treatment of brain diseases and strategies to improve delivery.
作者信息
Cabral Célia, Carbone Claudia, Maher Pamela, Castelo-Branco Miguel
机构信息
Faculty of Medicine, Clinic Academic Center of Coimbra (CACC), University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal.
Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal.
出版信息
Front Pharmacol. 2022 Oct 3;13:1032496. doi: 10.3389/fphar.2022.1032496. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Psychoactive natural products: Potential in the treatment of brain diseases and strategies to improve delivery.社论：精神活性天然产物：在脑部疾病治疗中的潜力及改善给药的策略
Front Pharmacol. 2022 Oct 3;13:1032496. doi: 10.3389/fphar.2022.1032496. eCollection 2022.
2
Biomedical analysis of New Psychoactive Substances (NPS) of natural origin.天然来源的新型精神活性物质（NPS）的生物医学分析。
J Pharm Biomed Anal. 2020 Feb 5;179:112945. doi: 10.1016/j.jpba.2019.112945. Epub 2019 Oct 30.
3
Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.新西兰新型精神活性物质（“合法兴奋剂”）法定监管市场下精神活性产品安全性监测的问题。
Drug Alcohol Rev. 2017 Sep;36(5):589-596. doi: 10.1111/dar.12507. Epub 2017 Feb 23.
4
What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.在新西兰新型精神活性物质（NPS，“合法兴奋剂”）的合法市场中，哪些产品被视为具有精神活性？对执法和处罚的影响。
Drug Test Anal. 2016 Aug;8(8):768-78. doi: 10.1002/dta.1943. Epub 2016 Feb 9.
5
The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution.在新西兰，为发展受监管的新精神活性物质（NPS）（“合法快感”）市场而禁止动物试验面临的挑战：解决问题的要点和方案。
Int J Drug Policy. 2015 Dec;26(12):1273-8. doi: 10.1016/j.drugpo.2015.08.006. Epub 2015 Aug 20.
6
Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.新西兰新型精神活性物质（NPS，“合法兴奋剂”）合法市场下的合法兴奋剂行业商业及游说策略。
Int J Drug Policy. 2016 Nov;37:90-97. doi: 10.1016/j.drugpo.2016.08.011. Epub 2016 Sep 15.
7
Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology.天然精神活性药物治疗中枢神经系统疾病的潜力：多药理学视角。
Curr Med Chem. 2021;28(1):53-68. doi: 10.2174/0929867326666191212103330.
8
Psychoactive natural products: overview of recent developments.精神活性天然产物：近期发展综述
Ann Ist Super Sanita. 2014;50(1):12-27. doi: 10.4415/ANN_14_01_04.
9
Lipid nanocarriers loaded with natural compounds: Potential new therapies for age related neurodegenerative diseases?载有天然化合物的脂质纳米载体：治疗与年龄相关的神经退行性疾病的潜在新疗法？
Prog Neurobiol. 2018 Sep;168:21-41. doi: 10.1016/j.pneurobio.2018.04.004. Epub 2018 Apr 8.
10
Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.政府批准的含有新精神活性物质的产品是否被认为比酒精、烟草和非法药物更安全、更被社会接受？新西兰警方逮捕人员调查的结果。
Drug Alcohol Rev. 2018 Mar;37(3):406-413. doi: 10.1111/dar.12655. Epub 2017 Dec 29.
本文引用的文献
1
A link between synaptic plasticity and reorganization of brain activity in Parkinson's disease.帕金森病中突触可塑性与大脑活动重组之间的联系。
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3). doi: 10.1073/pnas.2013962118.
Zotero 插件